Eupraxia Pharmaceuticals

EPRXNasdaq Canada Health Care Pharmaceuticals and Biotechnology

Market cap

$569.433 M

$8.64 +0.70%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$38.6M

Loss-making

Shares outstanding

51,939,206

Latest filing cover page

P/E ratio

—

Cap ÷ net income

What if Eupraxia Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$459,347.61

Per share 53,165× higher

Bitcoin $1.72T

$26,094.55

Per share 3,020× higher

Nvidia $5.48T

$83,145.78

Per share 9,623× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Eupraxia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.